Treatment of Chronic Hepatitis C with Amantadine
- 1 January 1997
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 42 (8), 1681-1687
- https://doi.org/10.1023/a:1018857314351
Abstract
Treatment of chronic hepatitis C infection withinterferon has been disappointing, with less than onethird of patients achieving a sustained response andmost experiencing significant side effects. For...Keywords
This publication has 32 references indexed in Scilit:
- Clinical Outcomes after Transfusion-Associated Hepatitis CNew England Journal of Medicine, 1995
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver DiseaseNew England Journal of Medicine, 1993
- The Natural History of Community-Acquired Hepatitis C in the United StatesNew England Journal of Medicine, 1992
- Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses.1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- TOXIC EFFECTS OF AMANTADINE IN PATIENTS WITH RENAL-FAILURE1979
- On the Mechanism of Inhibition of Influenza Virus Replication by Amantadine HydrochlorideJournal of General Virology, 1978
- Distribution and Excretion of 3H-Amantadine HClCHEMICAL & PHARMACEUTICAL BULLETIN, 1969